Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7711275rdf:typepubmed:Citationlld:pubmed
pubmed-article:7711275lifeskim:mentionsumls-concept:C0243071lld:lifeskim
pubmed-article:7711275lifeskim:mentionsumls-concept:C0439596lld:lifeskim
pubmed-article:7711275pubmed:issue4lld:pubmed
pubmed-article:7711275pubmed:dateCreated1995-5-18lld:pubmed
pubmed-article:7711275pubmed:abstractTextAs a continuation of the studies on chemotactic N-formylpeptides, we report here the synthesis and activity of a new cyclic analogue of the prototypical ligand For-Met-Leu-Phe-OMe. The new compound For-Met-Lys-Phe-For-Met-Lys-Phe- (4) contains a 20-membered cyclic moiety made up of a dimeric -Lys-Phe- sequence in which For-Met is attached to each Lys alpha-NH2 and hence remains outside the ring. The conformation in the crystal of the cyclic precursor of 4, namely Boc-Lys-Phe-Boc-Lys-Phe- (2) and the activity of the structurally related linear analogue For-Met-Lys(Z)-Phe-OBzl (6), have also been examined. The new analogues 4 and 6 are active as chemoattractants, secretagogues, and superoxide anion generating agents, when tested on human neutrophils. The structure-activity relationship is discussed and related to that of a previously studied cyclic model.lld:pubmed
pubmed-article:7711275pubmed:languageenglld:pubmed
pubmed-article:7711275pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7711275pubmed:citationSubsetIMlld:pubmed
pubmed-article:7711275pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7711275pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7711275pubmed:statusMEDLINElld:pubmed
pubmed-article:7711275pubmed:monthAprlld:pubmed
pubmed-article:7711275pubmed:issn0006-3525lld:pubmed
pubmed-article:7711275pubmed:authorpubmed-author:TorriniIIlld:pubmed
pubmed-article:7711275pubmed:authorpubmed-author:TranielloSSlld:pubmed
pubmed-article:7711275pubmed:authorpubmed-author:SpisaniSSlld:pubmed
pubmed-article:7711275pubmed:authorpubmed-author:MazzaFFlld:pubmed
pubmed-article:7711275pubmed:authorpubmed-author:ParadisiM PMPlld:pubmed
pubmed-article:7711275pubmed:authorpubmed-author:LucenteGGlld:pubmed
pubmed-article:7711275pubmed:authorpubmed-author:GavuzzoEElld:pubmed
pubmed-article:7711275pubmed:authorpubmed-author:PochettiGGlld:pubmed
pubmed-article:7711275pubmed:authorpubmed-author:ZecchiniG PGPlld:pubmed
pubmed-article:7711275pubmed:issnTypePrintlld:pubmed
pubmed-article:7711275pubmed:volume35lld:pubmed
pubmed-article:7711275pubmed:ownerNLMlld:pubmed
pubmed-article:7711275pubmed:authorsCompleteYlld:pubmed
pubmed-article:7711275pubmed:pagination347-58lld:pubmed
pubmed-article:7711275pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7711275pubmed:meshHeadingpubmed-meshheading:7711275-...lld:pubmed
pubmed-article:7711275pubmed:meshHeadingpubmed-meshheading:7711275-...lld:pubmed
pubmed-article:7711275pubmed:meshHeadingpubmed-meshheading:7711275-...lld:pubmed
pubmed-article:7711275pubmed:meshHeadingpubmed-meshheading:7711275-...lld:pubmed
pubmed-article:7711275pubmed:meshHeadingpubmed-meshheading:7711275-...lld:pubmed
pubmed-article:7711275pubmed:meshHeadingpubmed-meshheading:7711275-...lld:pubmed
pubmed-article:7711275pubmed:meshHeadingpubmed-meshheading:7711275-...lld:pubmed
pubmed-article:7711275pubmed:meshHeadingpubmed-meshheading:7711275-...lld:pubmed
pubmed-article:7711275pubmed:meshHeadingpubmed-meshheading:7711275-...lld:pubmed
pubmed-article:7711275pubmed:year1995lld:pubmed
pubmed-article:7711275pubmed:articleTitleFor-Met-Lys-Phe-For-Met-Lys-Phe-: a new cyclic analogue of the chemotactic formylpeptides.lld:pubmed
pubmed-article:7711275pubmed:affiliationDipartimento di Studi Farmaceutici, Chimica del Farmaco del CNR Università La Sapienza, Roma, Italy.lld:pubmed
pubmed-article:7711275pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7711275pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:7711275pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed